These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 4910199

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.
    Motomiya T, Atsumi T, Isokane N, Yamashita S, Sano T.
    Jpn Heart J; 1970 Sep; 11(5):433-49. PubMed ID: 4921577
    [No Abstract] [Full Text] [Related]

  • 3. Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).
    Walton KW, Craig GM, Prior P, Waterhouse JA, Skilton J.
    Br Heart J; 1973 Feb; 35(2):211-9. PubMed ID: 4570447
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of atherosclerosis obliterans with pyridinolcarbamate.
    Atsumi T, Motomiya T, Isokane N, Shimamoto T.
    Jpn Heart J; 1971 Jul; 12(4):335-46. PubMed ID: 5314713
    [No Abstract] [Full Text] [Related]

  • 6. [A double blind crossover trial in pyridinolcarbamate treatment of atherosclerosis obliterans].
    Yamashita S.
    Nihon Naika Gakkai Zasshi; 1969 Apr 10; 58(4):283-92. PubMed ID: 4896659
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of atherosclerosis by pyridinolcarbamate. Review of the history of the introduction of pyridinolcarbamate and its clinical results].
    Shimamoto T.
    Rev Atheroscler (Paris); 1968 Apr 10; 10(3):67-84. PubMed ID: 5746502
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical and plethysmographic evaluation in patients with peripheral arteriopathies treated with pyridinolcarbamate].
    Lucero Eseverri JA, Fajardo JD, Velles Aguirre L, Quijano E, Ciliberti E, Lucarelli R.
    Prensa Med Argent; 1970 Apr 24; 57(8):394-8. PubMed ID: 5517707
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of pyridinol carbamate (Anginin) in peripheral arterial blood circulation disorders].
    Heisig N, Westermann KW, Stolterfoht CA, Zaki J.
    Med Klin; 1970 Dec 25; 65(52):2289-93. PubMed ID: 5522670
    [No Abstract] [Full Text] [Related]

  • 14. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
    Majkowski J, Lysakowska-Sernicka K, Gajewska A, Bilińska-Nigot B, Ostrowski K, Semenicki K.
    Neurol Neurochir Pol; 1978 Dec 25; 12(4):387-96. PubMed ID: 714218
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Anginin (pyridinol carbamate) therapy of coronary atherosclerosis and obliterating atherosclerosis of the arteries of the lower extremities].
    Liusov VA, Belousov IuB, Martynov AI, Koroleva SA, Zimin VS.
    Kardiologiia; 1972 Nov 25; 12(11):39-45. PubMed ID: 4655879
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.